RxDoctor Payments Data

Evan Gerondale, PA

Medical · Grand Rapids, MINPI 1336730662

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.8% of the total across 256 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,081in general payments, 2019–2025

Across 256 payments — averaging $27.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Incyte Corporation$683
  • Johnson & Johnson$643
  • Dermavant Sciences, Inc.$590
  • Amgen$562
  • Sanofi$521
  • plus $3K from 22 others

What the payments were for

  • Food & beverage$6,63994%
  • Education$4426%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,081 in reported general payments places this provider in the 90th percentile of 755 medical providers in Michigan.

See all medical providers in Michigan

Medicare billing

Part B allowed, 2024
$74,888
Medicare patients
479
Services billed
1,849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate89$3,202
Azelaic Acid13$2,437
Tacrolimus18$2,230
Ketoconazole142$2,216
Fluocinonide70$2,162
Triamcinolone Acetonide119$1,863
Calcipotriene12$1,840
Fluorouracil25$1,476
Clindamycin Phosphate24$1,150
Metronidazole25$890
Doxycycline Hyclate47$752
Tretinoin12$593
Desonide22$542
Fluticasone Propionate17$503
Econazole Nitrate19$500

Paid to pharmacies, not to this prescriber.

Other medical in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →